Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy

RegulatoryapprovedWakixPositive

AI Analysis

Summary

Viatris received approval from Japan's Ministry of Health, Labour and Welfare for Wakix to treat excessive daytime sleepiness related to obstructive sleep apnea syndrome and narcolepsy types 1 and 2.

Outcome Details

Japan's Ministry of Health, Labour and Welfare approved Wakix for EDS related to OSAS and for narcolepsy types 1 and 2

Importance:6/10

Sentiment:

0.70

regulatory approvalJapannarcolepsysleep disorderobstructive sleep apnea

Related Companies

$VTRS

Read the original article

Published by Pharmaceutical Technology on September 17, 2026 8:40 AM

Read Original